Barbui C - Search Results

1

Amitriptyline versus other types of pharmacotherapy for depression.

Guaiana G, Barbui C, Hotopf M. Guaiana G, et al. Among authors: barbui c. Cochrane Database Syst Rev. 2003;(2):CD004186. doi: 10.1002/14651858.CD004186. Cochrane Database Syst Rev. 2003. PMID: 12804503 Updated. Review.

2

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM. Barbui C, et al. Cochrane Database Syst Rev. 2000;(4):CD002791. doi: 10.1002/14651858.CD002791. Cochrane Database Syst Rev. 2000. PMID: 11034764 Updated. Review.

3

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.

Barbui C, Hotopf M. Barbui C, et al. Br J Psychiatry. 2001 Feb;178:129-44. doi: 10.1192/bjp.178.2.129. Br J Psychiatry. 2001. PMID: 11157426 Review.

4

Forty years of antidepressant drug trials.

Barbui C, Hotopf M. Barbui C, et al. Acta Psychiatr Scand. 2001 Aug;104(2):92-5. doi: 10.1034/j.1600-0447.2001.00170.x. Acta Psychiatr Scand. 2001. PMID: 11473501 Review.

5

Regulatory issues in Europe.

Barbui C, Guaiana G, Garattini S. Barbui C, et al. J Clin Psychopharmacol. 2001 Dec;21(6):545-8. doi: 10.1097/00004714-200112000-00001. J Clin Psychopharmacol. 2001. PMID: 11762999 No abstract available.

6

[A systemic review of the European Agency for the evaluation of medicinal products (EMEA) recommendations on the conduct of clinical trials in psychiatry].

Guaiana G, Barbui C. Guaiana G, et al. Among authors: barbui c. Epidemiol Psichiatr Soc. 2002 Jan-Mar;11(1):28-34. doi: 10.1017/s1121189x00010125. Epidemiol Psichiatr Soc. 2002. PMID: 12043431 Italian.

7

Update of suicide trends in Italy from 1986 to 1996.

Guaiana G, D'Avanzo B, Barbui C. Guaiana G, et al. Among authors: barbui c. Soc Psychiatry Psychiatr Epidemiol. 2002 Jun;37(6):267-70. doi: 10.1007/s001270200018. Soc Psychiatry Psychiatr Epidemiol. 2002. PMID: 12111031

8

Fluoxetine dose and outcome in antidepressant drug trials.

Barbui C, Hotopf M, Garattini S. Barbui C, et al. Eur J Clin Pharmacol. 2002 Sep;58(6):379-86. doi: 10.1007/s00228-002-0497-7. Epub 2002 Aug 10. Eur J Clin Pharmacol. 2002. PMID: 12242596 Review.

9

Prescribing second-generation antipsychotics and the evolving standard of care in Italy.

Barbui C, Danese A, Guaiana G, Mapelli L, Miele L, Monzani E, Percudani M; Study Group. Barbui C, et al. Pharmacopsychiatry. 2002 Nov;35(6):239-43. doi: 10.1055/s-2002-36394. Pharmacopsychiatry. 2002. PMID: 12518273

10

Economic evaluation of antidepressive agents: a systematic critique of experimental and observational studies.

Barbui C, Percudani M, Hotopf M. Barbui C, et al. J Clin Psychopharmacol. 2003 Apr;23(2):145-54. doi: 10.1097/00004714-200304000-00007. J Clin Psychopharmacol. 2003. PMID: 12640216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page